ERCC1 protein, mRNA expression and T19007C polymorphism as prognostic markers in head and neck squamous cell carcinoma patients treated with surgery and adjuvant cisplatin-based chemoradiation (2011)
- Authors:
- USP affiliated authors: PASINI, FÁTIMA SOLANGE - FM ; FERRAZ, ALBERTO ROSSETTI - FM ; FEDERICO, MIRIAM HATSUE HONDA - FM
- Unidade: FM
- DOI: 10.1200/jco.2010.28.15_suppl.5540
- Subjects: POLIMORFISMO; MARCADOR MOLECULAR; PROGNÓSTICO; NEOPLASIAS DE CABEÇA E PESCOÇO (QUIMIOTERAPIA); CARCINOMA DE CÉLULAS ESCAMOSAS (CIRURGIA); QUIMIOTERAPIA ADJUVANTE; ANTINEOPLÁSICOS (TOXICIDADE)
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Oncology reports
- ISSN: 1021-335X
- Volume/Número/Paginação/Ano: v. 25, n. 3, p. 693-699, 2011
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
CASTRO, Gilberto de et al. ERCC1 protein, mRNA expression and T19007C polymorphism as prognostic markers in head and neck squamous cell carcinoma patients treated with surgery and adjuvant cisplatin-based chemoradiation. Oncology reports, v. 25, n. 3, p. 693-699, 2011Tradução . . Disponível em: https://doi.org/10.1200/jco.2010.28.15_suppl.5540. Acesso em: 30 abr. 2024. -
APA
Castro, G. de, Pasini, F. S., Siqueira, S. A. C., Ferraz, A. R., Villar, R. C., Snitcovsky, I. M. L., & Federico, M. H. H. (2011). ERCC1 protein, mRNA expression and T19007C polymorphism as prognostic markers in head and neck squamous cell carcinoma patients treated with surgery and adjuvant cisplatin-based chemoradiation. Oncology reports, 25( 3), 693-699. doi:10.1200/jco.2010.28.15_suppl.5540 -
NLM
Castro G de, Pasini FS, Siqueira SAC, Ferraz AR, Villar RC, Snitcovsky IML, Federico MHH. ERCC1 protein, mRNA expression and T19007C polymorphism as prognostic markers in head and neck squamous cell carcinoma patients treated with surgery and adjuvant cisplatin-based chemoradiation [Internet]. Oncology reports. 2011 ; 25( 3): 693-699.[citado 2024 abr. 30 ] Available from: https://doi.org/10.1200/jco.2010.28.15_suppl.5540 -
Vancouver
Castro G de, Pasini FS, Siqueira SAC, Ferraz AR, Villar RC, Snitcovsky IML, Federico MHH. ERCC1 protein, mRNA expression and T19007C polymorphism as prognostic markers in head and neck squamous cell carcinoma patients treated with surgery and adjuvant cisplatin-based chemoradiation [Internet]. Oncology reports. 2011 ; 25( 3): 693-699.[citado 2024 abr. 30 ] Available from: https://doi.org/10.1200/jco.2010.28.15_suppl.5540 - ERCC1 protein, mRNA expression, and T19007C polymorphism as prognostic markers in head and neck squamous cell carcinoma (HNSCC) patients treated with surgery and adjuvant cisplatin-based chemoradiation (CRT)
- Determination of plasma osteopontin levels in patients with head and neck squamous cell carcinoma
- HMGCR MRNA expression in tongue squamous cell carcinoma
- Adjuvant chemoradiation (CRT) in head and neck squamous cell carcinoma (HNSCC) patients presenting with high or intermediate risk features and delayed overall treatment time (OTT)
- New possible predictive marker of survival in oral squamous cell carcinoma
- Low post chemoradiotherapy plasma osteopontin level may be marker of clinical benefit in inoperable squamous cell head and neck carcinoma patients
- Gene expression pattern of primary oral cancer is predictive of cervical lymph node metastases
- Expression of CXCR1 and 'CX IND. 3'CR1 mRNA seems to outocome of the larynx squamous cell carcinoma
- Avaliação prospectiva de polimorfismo genéticos da glutationa-s-transferase P1 como fator prognóstico e preditivo de resposta em pacientes portadores de carcinoma epidermóide de cabeça e pescoço tratados com quimiorradioterapia
- Identification of polymorphisms and germline mutations in BRCA1 genes in breast cancer patients indicated for genetic test
Informações sobre o DOI: 10.1200/jco.2010.28.15_suppl.5540 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
